| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Microbiology and
Cell and Molecular Biology Program, School of Medicine, University of Nevada, Reno, NV 89557; and
Division of Infectious Diseases,
§
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461
The capsular swelling or quellung reaction was reported almost 100 years ago and described the effect of Abs on the appearance of microbial capsules. Despite widespread use to assess Ab binding to capsules, relatively little is known as to the mechanism of this effect or its biological consequences. The fungus Cryptococcus neoformans is an attractive system to study capsule reactions because it has a large polysaccharide capsule that is readily visible by light microscopy. When viewed by differential interference contrast microscopy, binding of mAb to C. neoformans cells produced two distinct capsular reactions that depended on the Ab epitope specificity and the yeast serotype. In the first pattern, termed "rim," the capsule appears transparent with a highly refractive outer edge. In the second pattern, termed "puffy," the capsule appears opaque and lacks a highly refractive outer rim. mAbs that bind with a rim pattern suppress the overall rate of C3 deposition on the yeast via the classical and alternative complement pathways. In contrast, mAbs that bind with a puffy pattern do not affect C3 deposition. Protective and nonprotective IgM mAbs produce rim and puffy patterns, respectively. These results indicate that: 1) capsule reactions are a consequence of Ab-induced changes in capsular refractive index; 2) the type of capsule reaction depends on the Ab specificity; and 3) Ab-induced changes in refractive index correlate with biological activities important for host defense against C. neoformans. Our results provide the first evidence associating distinct capsule reaction patterns with Ab biological activity.
This article has been cited by other articles:
|
|
 |
|
  D. O. Beenhouwer, E. M. Yoo, C.-W. Lai, M. A. Rocha, and S. L. Morrison Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice against Cryptococcus neoformans Infection Infect. Immun., March 1, 2007; 75(3): 1424 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Kozel, P. Thorkildson, S. Brandt, W. H. Welch, J. A. Lovchik, D. P. AuCoin, J. Vilai, and C. R. Lyons Protective and Immunochemical Activities of Monoclonal Antibodies Reactive with the Bacillus anthracis Polypeptide Capsule Infect. Immun., January 1, 2007; 75(1): 152 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Gates and T. R. Kozel Differential Localization of Complement Component 3 within the Capsular Matrix of Cryptococcus neoformans. Infect. Immun., June 1, 2006; 74(6): 3096 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Kelly, J. Chen, L. E. Yauch, and S. M. Levitz Opsonic Requirements for Dendritic Cell-Mediated Responses to Cryptococcus neoformans Infect. Immun., January 1, 2005; 73(1): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zaragoza and A. Casadevall Antibodies Produced in Response to Cryptococcus neoformans Pulmonary Infection in Mice Have Characteristics of Nonprotective Antibodies Infect. Immun., July 1, 2004; 72(7): 4271 - 4274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Martinez, D. Moussai, and A. Casadevall Antibody to Cryptococcus neoformans Glucuronoxylomannan Inhibits the Release of Capsular Antigen Infect. Immun., June 1, 2004; 72(6): 3674 - 3679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. McFadden and A. Casadevall Unexpected Diversity in the Fine Specificity of Monoclonal Antibodies That Use the Same V Region Gene to Glucuronoxylomannan of Cryptococcus neoformans J. Immunol., March 15, 2004; 172(6): 3670 - 3677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brandt, P. Thorkildson, and T. R. Kozel Monoclonal Antibodies Reactive with Immunorecessive Epitopes of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans Clin. Vaccine Immunol., September 1, 2003; 10(5): 903 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Kozel, S. M. Levitz, F. Dromer, M. A. Gates, P. Thorkildson, and G. Janbon Antigenic and Biological Characteristics of Mutant Strains of Cryptococcus neoformans Lacking Capsular O Acetylation or Xylosyl Side Chains Infect. Immun., May 1, 2003; 71(5): 2868 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Duro, D. Netski, P. Thorkildson, and T. R. Kozel Contribution of Epitope Specificity to the Binding of Monoclonal Antibodies to the Capsule of Cryptococcus neoformans and the Soluble Form of Its Major Polysaccharide, Glucuronoxylomannan Clin. Vaccine Immunol., March 1, 2003; 10(2): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Beenhouwer, R. J. May, P. Valadon, and M. D. Scharff High Affinity Mimotope of the Polysaccharide Capsule of Cryptococcus neoformans Identified from an Evolutionary Phage Peptide Library J. Immunol., December 15, 2002; 169(12): 6992 - 6999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. McLean, M. Torres, N. Elguezabal, A. Nakouzi, and A. Casadevall Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen J. Immunol., August 1, 2002; 169(3): 1379 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Netski and T. R. Kozel Fc-Dependent and Fc-Independent Opsonization of Cryptococcus neoformans by Anticapsular Monoclonal Antibodies: Importance of Epitope Specificity Infect. Immun., June 1, 2002; 70(6): 2812 - 2819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rivera, J. Mukherjee, L. M. Weiss, and A. Casadevall Antibody Efficacy in Murine Pulmonary Cryptococcus neoformans Infection: A Role for Nitric Oxide J. Immunol., April 1, 2002; 168(7): 3419 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Shin, J. S. Lin, P. W. Anderson, R. A. Insel, and M. H. Nahm Monoclonal Antibodies Specific for Neisseria meningitidis Group B Polysaccharide and Their Peptide Mimotopes Infect. Immun., May 1, 2001; 69(5): 3335 - 3342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakouzi, P. Valadon, J. Nosanchuk, N. Green, and A. Casadevall Molecular Basis for Immunoglobulin M Specificity to Epitopes in Cryptococcus neoformans Polysaccharide That Elicit Protective and Nonprotective Antibodies Infect. Immun., May 1, 2001; 69(5): 3398 - 3409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. MacGill, R. S. MacGill, and T. R. Kozel Capsular Reactions of Cryptococcus neoformans with Polyspecific and Oligospecific Polyclonal Anticapsular Antibodies Infect. Immun., February 1, 2001; 69(2): 1189 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Taborda and A. Casadevall Immunoglobulin M Efficacy Against Cryptococcus neoformans: Mechanism, Dose Dependence, and Prozone-Like Effects in Passive Protection Experiments J. Immunol., February 1, 2001; 166(3): 2100 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sun, Y.-i. Hwang, and M. H. Nahm Avidity, Potency, and Cross-Reactivity of Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide Serotype 6B Infect. Immun., January 1, 2001; 69(1): 336 - 344. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
